Plain-English translation of NCT06752239 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a slightly different way of planning radiation therapy can protect your thyroid better while still effectively treating nasopharyngeal cancer. Nasopharyngeal cancer is a cancer that starts in the upper part of your throat, behind your nose. Radiation therapy is a standard treatment, but it can sometimes damage the thyroid gland and cause hypothyroidism (an underactive thyroid). This study compares a modified radiation planning approach designed to spare more of the thyroid against the standard approach.
Radiation therapy is essential for treating nasopharyngeal cancer, but it can harm the thyroid gland, leading to lifelong thyroid problems and the need for hormone replacement therapy. This trial exists to see if a refined radiation planning technique can reduce thyroid damage while maintaining the same cancer-fighting effectiveness.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive radiation therapy planned using either the standard approach or the modified approach that better spares the thyroid. Both groups receive the same radiation dose to treat the cancer—only the planning method differs. You will attend radiation treatment sessions and follow-up visits to check your thyroid function, assess quality of life, and monitor for side effects throughout the study period. The study involves multiple cancer centers, so your local hospital may be participating.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China